Pcn77 - Budget Impact Analysis of Blinatumomab for the Treatment of Pediatric Patients With Philadelphia Negative Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in Mexico

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.159
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV